Travere Therapeutics Inc
TVTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.13B
Close$
Share Statistics
| Market cap | $5.13 Billion |
|---|---|
| Enterprise Value | $5.38 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.14 |
| Outstanding Shares | 91,868,862 |
Return
| Return on Equity | -44.87% |
|---|---|
| Return on Assets | -7.98% |
| Return on Invested Capital | -10.87% |
Valuation & Multiples
| P/E Ratio | -236.51 |
|---|---|
| PEG | 2364.32 |
| Price to Sales | 11.19 |
| Price to Book Ratio | 55.95 |
| Enterprise Value to Revenue | 10.03 |
| Enterprise Value to EBIT | -115.1 |
| Enterprise Value to Net Income | -122 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 3.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
$136.24 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$160.66 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7182▼ 56.79% |
|---|---|
| Total Calls | 2,603,400▲ 31.05% |
| Total Puts | 1,869,800▼ 26.82% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 113.61%▼ 0.92% |
|---|---|
| Total Invested | $3.01B▼ 22.89% |
| Investors Holding | 279▼ 22.00% |
ESG Score
No data